Stanford Medicine researchers in the Mark Skylar-Scott Lab have developed "STIR" (Syringe Tumbler for Ink Resuspension), an in-syringe bioink cell mixing system with near-zero dead volume that virtually eliminates cell settling without impacting the usable amount of bio